Browse Arkansas Code titles and sections
21 U.S.C. § 387a — FDA authority over tobacco products
Federal law — U.S. Code and appendices · legal_authorities
Page 668
TITLE 21—FOOD AND DRUGS
§ 387a
marketing, and distribution of tobacco products as
provided for in this division;
‘‘(2) to ensure that the Food and Drug Administra-
tion has the authority to address issues of particular
concern to public health officials, especially the use
of tobacco by young people and dependence on to-
bacco;
‘‘(3) to authorize the Food and Drug Administration
to set national standards controlling the manufac-
ture of tobacco products and the identity, public dis-
closure, and amount of ingredients used in such prod-
ucts;
‘‘(4) to provide new and flexible enforcement au-
thority to ensure that there is effective oversight of
the tobacco industry’s efforts to develop, introduce,
and promote less harmful tobacco products;
‘‘(5) to vest the Food and Drug Administration with
the authority to regulate the levels of tar, nicotine,
and other harmful components of tobacco products;
‘‘(6) in order to ensure that consumers are better
informed, to require tobacco product manufacturers
to disclose research which has not previously been
made available, as well as research generated in the
future, relating to the health and dependency effects
or safety of tobacco products;
‘‘(7) to continue to permit the sale of tobacco prod-
ucts to adults in conjunction with measures to ensure
that they are not sold or accessible to underage pur-
chasers;
‘‘(8) to impose appropriate regulatory controls on
the tobacco industry;
‘‘(9) to promote cessation to reduce disease risk and
the social costs associated with tobacco-related dis-
eases; and
‘‘(10) to strengthen legislation against illicit trade
in tobacco products.’’
MODIFICATION OF DEADLINES FOR SECRETARIAL ACTION
Pub. L. 111–31, div. A, § 6, June 22, 2009, 123 Stat. 1783,
provided that:
Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 387a
Stored review status: historical_2024_not_currentness_verified. A text match is a research starting point; applicability is not established.
Original supplied file — preserved unchanged
Download original Markdown file
File SHA-256: 0d580ac071199c0b2a9f744040fe3497c2e45785d428a5648f5bdc1c1f4779be. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.
Authority boundary: historical or unconfirmed source not current law verified.
Open the recorded source website ↗
Record provenance
Stable record: federal_law:legal_authorities:usc2024-73181207bd48a49df7f774f3
Source file: Laws/federal/codes/united-states-code-2024/title-21/section-387a-fda-authority-over-tobacco-products--9799dcac8f.md
Pages: Not recorded – Not recorded
Passage SHA-256: 96675c9c5bf7bea4cd58a78c332fca9720dc89a03d63dea7a07ba9050f8b937a
Source location: USCODE-2024-title21-chap9-subchapIX-sec387a.pdf
Stored source content
Page 668
TITLE 21—FOOD AND DRUGS
§ 387a
marketing, and distribution of tobacco products as
provided for in this division;
‘‘(2) to ensure that the Food and Drug Administra-
tion has the authority to address issues of particular
concern to public health officials, especially the use
of tobacco by young people and dependence on to-
bacco;
‘‘(3) to authorize the Food and Drug Administration
to set national standards controlling the manufac-
ture of tobacco products and the identity, public dis-
closure, and amount of ingredients used in such prod-
ucts;
‘‘(4) to provide new and flexible enforcement au-
thority to ensure that there is effective oversight of
the tobacco industry’s efforts to develop, introduce,
and promote less harmful tobacco products;
‘‘(5) to vest the Food and Drug Administration with
the authority to regulate the levels of tar, nicotine,
and other harmful components of tobacco products;
‘‘(6) in order to ensure that consumers are better
informed, to require tobacco product manufacturers
to disclose research which has not previously been
made available, as well as research generated in the
future, relating to the health and dependency effects
or safety of tobacco products;
‘‘(7) to continue to permit the sale of tobacco prod-
ucts to adults in conjunction with measures to ensure
that they are not sold or accessible to underage pur-
chasers;
‘‘(8) to impose appropriate regulatory controls on
the tobacco industry;
‘‘(9) to promote cessation to reduce disease risk and
the social costs associated with tobacco-related dis-
eases; and
‘‘(10) to strengthen legislation against illicit trade
in tobacco products.’’
MODIFICATION OF DEADLINES FOR SECRETARIAL ACTION
Pub. L. 111–31, div. A, § 6, June 22, 2009, 123 Stat. 1783,
provided that:
‘‘(a) DELAYED COMMENCEMENT OF DATES FOR SECRE-
TARIAL ACTION.—
‘‘(1) IN GENERAL.—Except as provided in subsection
(c), with respect to any time periods specified in this
division [see Short Title of 2009 Amendment note set
out under section 301 of this title] (or in an amend-
ment made by this division) that begin on the date of
enactment of this Act [June 22, 2009], within which
the Secretary of Health and Human Services is re-
quired to carry out and complete specified activities,
the calculation of such time periods shall commence
on the date described in subsection (b).
‘‘(2) LIMITATION.—Subsection (a) shall only apply
with respect to obligations of the Secretary of Health
and Human Services that must be completed within
a specified time period and shall not apply to the ob-
ligations of any other person or to any other provi-
sion of this division (including the amendments made
by this division) that do not create such obligations
of the Secretary and are not contingent on actions by
the Secretary.
‘‘(b) DATE DESCRIBED.—The date described in this sub-
section is the first day of the first fiscal quarter fol-
lowing the initial 2 consecutive fiscal quarters of fiscal
year 2010 for which the Secretary of Health and Human
Services has collected fees under section 919 of the Fed-
eral Food, Drug, and Cosmetic Act [21 U.S.C. 387s] (as
added by section 101).
‘‘(c) EXCEPTION.—Subsection (a) shall not apply to
any time period (or date) contained—
‘‘(1) in section 102 [21 U.S.C. 387a–1], except that the
reference to ‘180 days’ in subsection (a)(1) of such sec-
tion shall be deemed to be ‘270 days’; and
‘‘(2) in sections 201 through 204 [amending sections
1333, 1334, and 4402 of Title 15, Commerce and Trade,
and enacting provisions set out as notes under sec-
tions 1333 and 4402 of Title 15] (or the amendments
made by any such sections).
‘‘(d) ADJUSTMENT.—The Secretary of Health and
Human Services may extend or reduce the duration of
one or more time periods to which subsection (a) ap-
plies if the Secretary determines appropriate [sic], ex-
cept that no such period shall be extended for more
than 90 days.’’
§ 387a. FDA authority over tobacco products
(a) In general
Tobacco products, including modified risk to-
bacco products for which an order has been
issued in accordance with section 387k of this
title, shall be regulated by the Secretary under
this subchapter and shall not be subject to the
provisions of subchapter V.
(b) Applicability
This subchapter shall apply to all cigarettes,
cigarette tobacco, roll-your-own tobacco, and
smokeless tobacco and to any other tobacco
products that the Secretary by regulation deems
to be subject to this subchapter. This subchapter
shall also apply to any tobacco product con-
taining nicotine that is not made or derived
from tobacco.
(c) Scope
(1) In general
Nothing in this subchapter, or any policy
issued or regulation promulgated thereunder,
or in sections 101(a), 102, or 103 of title I, title
II, or title III of the Family Smoking Preven-
tion and Tobacco Control Act, shall be con-
strued to affect, expand, or limit the Sec-
retary’s authority over (including the author-
ity to determine whether products may be reg-
ulated), or the regulation of, products under
this chapter that are not tobacco products
under subchapter V or any other subchapter.
(2) Limitation of authority
(A) In general
The provisions of this subchapter shall not
apply to tobacco leaf that is not in the pos-
session of a manufacturer of tobacco prod-
ucts, or to the producers of tobacco leaf, in-
cluding tobacco growers, tobacco ware-
houses, and tobacco grower cooperatives, nor
shall any employee of the Food and Drug Ad-
ministration have any authority to enter
onto a farm owned by a producer of tobacco
leaf without the written consent of such pro-
ducer.
(B) Exception
Notwithstanding subparagraph (A), if a
producer of tobacco leaf is also a tobacco
product manufacturer or controlled by a to-
bacco product manufacturer, the producer
shall be subject to this subchapter in the
producer’s capacity as a manufacturer. The
exception in this subparagraph shall not
apply to a producer of tobacco leaf who
grows tobacco under a contract with a to-
bacco product manufacturer and who is not
otherwise engaged in the manufacturing
process.
(C) Rule of construction
Nothing in this subchapter shall be con-
strued to grant the Secretary authority to
promulgate regulations on any matter that
involves the production of tobacco leaf or a
producer thereof, other than activities by a
manufacturer affecting production.
Page 669
TITLE 21—FOOD AND DRUGS
§ 387a–1
1 So in original. Probably should be ‘‘chapter IX’’.
2 So in original. The comma probably should not appear.
(d) Rulemaking procedures
Each rulemaking under this subchapter shall
be in accordance with chapter 5 of title 5. This
subsection shall not be construed to affect the
rulemaking provisions of section 102(a) of the
Family Smoking Prevention and Tobacco Con-
trol Act [21 U.S.C. 387a–1(a)].
(e) Center for tobacco products
Not later than 90 days after June 22, 2009, the
Secretary shall establish within the Food and
Drug Administration the Center for Tobacco
Products, which shall report to the Commis-
sioner of Food and Drugs in the same manner as
the other agency centers within the Food and
Drug Administration. The Center shall be re-
sponsible for the implementation of this sub-
chapter and related matters assigned by the
Commissioner.
(f) Office to assist small tobacco product manu-
facturers
The Secretary shall establish within the Food
and Drug Administration an identifiable office
to provide technical and other nonfinancial as-
sistance to small tobacco product manufactur-
ers to assist them in complying with the re-
quirements of this chapter.
(g) Consultation prior to rulemaking
Prior to promulgating rules under this sub-
chapter, the Secretary shall endeavor to consult
with other Federal agencies as appropriate.
(June 25, 1938, ch. 675, § 901, as added Pub. L.
111–31, div. A, title I, § 101(b)(3), June 22, 2009, 123
Stat. 1786; amended Pub. L. 117–103, div. P, title
I, § 111(b), Mar. 15, 2022, 136 Stat. 789.)
Editorial Notes
REFERENCES IN TEXT
The Family Smoking Prevention and Tobacco Con-
trol Act, referred to in subsec. (c)(1), is div. A of Pub.
L. 111–31, June 22, 2009, 123 Stat. 1776. Section 101(a) of
title I of the Act amended section 321 of this title. Sec-
tion 102 of title I of the Act enacted section 387a–1 of
this title. Section 103 of title I of the Act amended sec-
tions 331, 333, 334, 355, 360m, 372 to 374, 375, 379a, 381, 393,
399, and 679 of this title and enacted provisions set out
as notes under sections 331, 333, and 387c of this title.
Title II of the Act amended sections 1333, 1334, 4402, and
4406 of Title 15, Commerce and Trade, and enacted pro-
visions set out as notes under sections 1333 and 4402 of
Title 15. Title III of the Act enacted section 387t of this
title. For complete classification of this Act to the
Code, see Short Title of 2009 Amendment note set out
under section 301 of this title and Tables.
PRIOR PROVISIONS
A prior section 901 of act June 25, 1938, was renum-
bered section 1001 and is classified to section 391 of this
title.
AMENDMENTS
2022—Subsec. (b). Pub. L. 117–103 inserted at end
‘‘This subchapter shall also apply to any tobacco prod-
uct containing nicotine that is not made or derived
from tobacco.’’
Statutory Notes and Related Subsidiaries
EFFECTIVE DATE OF 2022 AMENDMENT
Amendment by Pub. L. 117–103 effective 30 days after
Mar. 15, 2022, see section 111(c) of Pub. L. 117–103, div.
P, title I, Mar. 15, 2022, 136 Stat. 789, set out as a note
under section 321 of this title.
§ 387a–1. Final rule
(a) Cigarettes and smokeless tobacco
(1) In general
On the first day of publication of the Federal
Register that is 180 days or more after June 22,
2009, the Secretary of Health and Human Serv-
ices shall publish in the Federal Register a
final rule regarding cigarettes and smokeless
tobacco, which—
(A) is deemed to be issued under chapter 9 1
of the Federal Food, Drug, and Cosmetic Act
[21 U.S.C. 387 et seq.], as added by section 101
of this division; and
(B) shall be deemed to be in compliance
with all applicable provisions of chapter 5 of
title 5 and all other provisions of law relat-
ing to rulemaking procedures.
(2) Contents of rule
Except as provided in this subsection, the
final rule published under paragraph (1),2 shall
be identical in its provisions to part 897 of the
regulations promulgated by the Secretary of
Health and Human Services in the August 28,
1996, issue of the Federal Register (61 Fed. Reg.
44615–44618). Such rule shall—
(A) provide for the designation of jurisdic-
tional authority that is in accordance with
this subsection in accordance with this divi-
sion and the amendments made by this divi-
sion;
(B) strike Subpart C—Labels and section
897.32(c);
(C) strike paragraphs (a), (b), and (i) of sec-
tion 897.3 and insert definitions of the terms
‘‘cigarette’’,
‘‘cigarette
tobacco’’,
and
‘‘smokeless tobacco’’ as defined in section
900 of the Federal Food, Drug, and Cosmetic
Act [21 U.S.C. 387];
(D) insert ‘‘or roll-your-own paper’’ in sec-
tion 897.34(a) after ‘‘other than cigarettes or
smokeless tobacco’’;
(E) include such modifications to section
897.30(b), if any, that the Secretary deter-
mines are appropriate in light of governing
First Amendment case law, including the de-
cision of the Supreme Court of the United
States in Lorillard Tobacco Co. v. Reilly (533
U.S. 525 (2001));
(F) become effective on the date that is 1
year after June 22, 2009; and
(G) amend paragraph (d) of section 897.16
to read as follows:
‘‘(d)(1) Except as provided in subparagraph (2),
no manufacturer, distributor, or retailer may
distribute or cause to be distributed any free
samples of cigarettes, smokeless tobacco, or
other tobacco products (as such term is defined
in section 201 of the Federal Food, Drug, and
Cosmetic Act).
‘‘(2)(A) Subparagraph (1) does not prohibit a
manufacturer, distributor, or retailer from dis-
tributing or causing to be distributed free sam-
ples of smokeless tobacco in a qualified adult-
only facility.
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Federal law — U.S. Code and appendices · legal_authorities
In this subchapter:
(1) **Additive** — The term “additive” means any substance the intended use of which results or may reasonably be expected to result, directly or indirectly, in its becoming a component or otherwise affecting the characteristic of any tobacco product (including any substances intended for use as a flavoring or coloring or in producing, manufacturing, packing, processing, preparing, treating, packaging, transporting, or holding), except that such term does not include tobacco or a pesticide chemical residue in or on raw tobacco or a pesticide chemical.
(2) **Brand** — The term “brand” means a variety of tobacco product distinguished by the tobacco used, tar content, nicotine content, flavoring used, size, filtration, packaging, logo, registered trademark, brand name, identifiable pattern of colors, or any combination of such attributes.
(3) **Cigarette** — The term “cigarette”—
(A) means a product that—
(i) is a tobacco product; and
(ii) meets the definition of the term “cigarette” in [section 1332(1) of title 15](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section1332/1&num=0&edition=prelim); and
(B) includes tobacco, in any form, that is functional in the product, which, because of its appearance, the type of tobacco used in the filler, or its packaging and labeling, is likely to be offered to, or purchased by, consumers as a cigarette or as roll-your-own tobacco.
(4) **Cigarette tobacco** — The term “cigarette tobacco” means any product that consists of loose tobacco that is intended for use by consumers in a cigarette. Unless otherwise stated, the requirements applicable to cigarettes under this subchapter shall also apply to cigarette tobacco.
(5) **Commerce** — The term “commerce” has the meaning giv
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 387
Stored review status: release_metadata_unconfirmed. The source passage cites 21 U.S.C. § 387. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
Page 664
TITLE 21—FOOD AND DRUGS
§ 387
1040, which is classified generally to this chapter. For
complete classification of this Act to the Code, see sec-
tion 301 of this title and Tables.
Statutory Notes and Related Subsidiaries
CODIFICATION
Section was enacted as part of the Stop Counterfeit
Drugs by Regulating and Enhancing Enforcement Now
Act, also known as the SCREEN Act, and also as part
of the Substance Use–Disorder Prevention that Pro-
motes Opioid Recovery and Treatment for Patients and
Communities Act, also known as the SUPPORT for Pa-
tients and Communities Act, and not as part of the
Federal Food, Drug, and Cosmetic Act which comprises
this chapter.
SUBCHAPTER IX—TOBACCO PRODUCTS
Editorial Notes
PRIOR PROVISIONS
A prior subchapter IX of this chapter, consisting of
sections 391 to 399a of this title, was redesignated sub-
chapter X by Pub. L. 111–31, div. A, title I, § 101(b)(1),
June 22, 2009, 123 Stat. 1784.
§ 387. Definitions
In this subchapter:
(1) Additive
The term ‘‘additive’’ means any substance
the intended use of which results or may rea-
sonably be expected to result, directly or indi-
rectly, in its becoming a component or other-
wise affecting the characteristic of any to-
bacco product (including any substances in-
tended for use as a flavoring or coloring or in
producing,
manufacturing,
packing,
proc-
essing, preparing, treating, packaging, trans-
porting, or holding), except that such term
does not include tobacco or a pesticide chem-
ical residue in or on raw tobacco or a pesticide
chemical.
(2) Brand
The term ‘‘brand’’ means a variety of to-
bacco product distinguished by the tobacco
used, tar content, nicotine content, flavoring
used, size, filtration, packaging, logo, reg-
istered trademark, brand name, identifia
Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 387
Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 387. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
**(a) In general** Tobacco products, including modified risk tobacco products for which an order has been issued in accordance with [section 387k of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387k&num=0&edition=prelim), shall be regulated by the Secretary under this subchapter and shall not be subject to the provisions of subchapter V.
**(b) Applicability** This subchapter shall apply to all cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco and to any other tobacco products that the Secretary by regulation deems to be subject to this subchapter. This subchapter shall also apply to any tobacco product containing nicotine that is not made or derived from tobacco.
**(c) Scope**
(1) **In general** — Nothing in this subchapter, or any policy issued or regulation promulgated thereunder, or in sections 101(a), 102, or 103 of title I, title II, or title III of the Family Smoking Prevention and Tobacco Control Act, shall be construed to affect, expand, or limit the Secretary’s authority over (including the authority to determine whether products may be regulated), or the regulation of, products under this chapter that are not tobacco products under subchapter V or any other subchapter.
(2) **Limitation of authority**
(A) *In general* — The provisions of this subchapter shall not apply to tobacco leaf that is not in the possession of a manufacturer of tobacco products, or to the producers of tobacco leaf, including tobacco growers, tobacco warehouses, and tobacco grower cooperatives, nor shall any employee of the Food and Drug Administration have any authority to enter onto a farm owned by a producer of tobacco leaf without the written consent of such producer.
(B) *Exception* — Notwithstanding subpa
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 387a
Stored review status: release_metadata_unconfirmed. Same stored citation; legal effect and authority still require review.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Establishment of quarterly fee** Beginning on June 22, 2009, the Secretary shall in accordance with this section assess user fees on, and collect such fees from, each manufacturer and importer of tobacco products subject to this subchapter. The fees shall be assessed and collected with respect to each quarter of each fiscal year, and the total amount assessed and collected for a fiscal year shall be the amount specified in subsection (b)(1) for such year, subject to subsection (c).
**(b) Assessment of user fee**
(1) **Amount of assessment** — The total amount of user fees authorized to be assessed and collected under subsection (a) for a fiscal year is the following, as applicable to the fiscal year involved:
(A) For fiscal year 2009, $85,000,000 (subject to subsection (e)).
(B) For fiscal year 2010, $235,000,000.
(C) For fiscal year 2011, $450,000,000.
(D) For fiscal year 2012, $477,000,000.
(E) For fiscal year 2013, $505,000,000.
(F) For fiscal year 2014, $534,000,000.
(G) For fiscal year 2015, $566,000,000.
(H) For fiscal year 2016, $599,000,000.
(I) For fiscal year 2017, $635,000,000.
(J) For fiscal year 2018, $672,000,000.
(K) For fiscal year 2019 and each subsequent fiscal year, $712,000,000.
(2) **Allocations of assessment by class of tobacco products**
(A) *In general* — The total user fees assessed and collected under subsection (a) each fiscal year with respect to each class of tobacco products shall be an amount that is equal to the applicable percentage of each class for the fiscal year multiplied by the amount specified in paragraph (1) for the fiscal year.
(B) *Applicable percentage*
(i) *In general* — For purposes of subparagraph (A), the applicable percentage for a fiscal year for each of the following
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 387s
Stored review status: release_metadata_unconfirmed. The source passage cites 21 U.S.C. § 387s. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
Page 695
TITLE 21—FOOD AND DRUGS
§ 387s
ings of the committee or otherwise engaged in
its business, shall be entitled to receive com-
pensation at rates to be fixed by the Sec-
retary, which may not exceed the daily equiv-
alent of the rate in effect under the Senior Ex-
ecutive Schedule under section 5382 of title 5,
for each day (including travel time) they are
so engaged; and while so serving away from
their homes or regular places of business each
member may be allowed travel expenses, in-
cluding per diem in lieu of subsistence, as au-
thorized by section 5703 of title 5 for persons in
the Government service employed intermit-
tently.
(2) Administrative support
The Secretary shall furnish the Advisory
Committee clerical and other assistance.
(3) Nonapplication of chapter 10 of title 5
Section 1013 of title 5 does not apply to the
Advisory Committee.
(e) Proceedings of advisory panels and commit-
tees
The Advisory Committee shall make and
maintain a transcript of any proceeding of the
panel or committee. Each such panel and com-
mittee shall delete from any transcript made
under this subsection information which is ex-
empt from disclosure under section 552(b) of
title 5.
(June 25, 1938, ch. 675, § 917, as added Pub. L.
111–31, div. A, title I, § 101(b)(3), June 22, 2009, 123
Stat. 1824; amended Pub. L. 117–286, § 4(a)(160),
Dec. 27, 2022, 136 Stat. 4323.)
Editorial Notes
AMENDMENTS
2022—Subsec. (d). Pub. L. 117–286, § 4(a)(160)(A), sub-
stituted ‘‘chapter 10 of title 5’’ for ‘‘FACA’’ in heading.
Subsec. (d)(3). Pub. L. 117–286, § 4(a)(160)(B), sub-
stituted ‘‘chapter 10 of title 5’’ for ‘‘FACA’’ in heading
and ‘‘Section 1013 of title 5’’ for ‘‘Section 14 of the Fed-
eral Advisory Committee Act’’ in text.
Statutory Notes and Related Subsidi
Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 387s
Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 387s. This identifies an authority to review, not proof of applicability.